Table 1 Characteristics of the study population
All patients (n = 117) | |
|---|---|
Age (years) | 63 (58-67) |
Gender (men/women) | 71/46 |
Height (cm) | 168 (166-170) |
Weight (kg) | 75 (71-79) |
SAPS II | 53 (47-58) |
Pre-existing cardiac disease, n (%) | 35 (30) |
Hypertension, n (%) | 26 (33) |
Pre-existing COPD, n (%) | 16 (14) |
Dobutamine infusion, n (%) | 10 (9) |
Dose μg/kg/min | 4.8 (3.5-5.0) |
Epinephrine-norepinephrine, n (%) | 15 (15) |
Dose μg/kg/min | 0.11 (0.08-0.14) |
Diuretic therapy before SBT, n (%) | 14 (12) |
Duration of mechanical ventilation (days) | 5.0 (5.0-6.5) |
Mortality, n (%) | 11 (10) |